Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01573962 · ClinicalTrials.gov registry record
A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury
A clinical trial, sponsored by Astute Medical.
- Completed
- Registry status
- 420
- Enrollment target
NCT01573962: Completed study, sponsored by Astute Medical.
NCT01573962 is a clinical trial that has completed, run by Astute Medical. The registered enrollment target is 420 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01573962 has completed, sponsored by Astute Medical.
- COMPLETED
- Registry status
- 420 participants
- Enrollment target
Study Summary
The objective of this sample collection study is to collect blood and urine samples. This study is observational and will have no impact on the medical management of the subject.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-12 |
What the finished NCT01573962 record still lists
NCT01573962 is an observational study that tracks outcomes without assigning an intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01573962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01573962 about?
NCT01573962 is a clinical study titled "A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury". The objective of this sample collection study is to collect blood and urine samples. This study is observational and will have no impact on the medical management of the subject.
What is the current status of trial NCT01573962?
This trial is currently completed. The enrollment target is 420 participants. The study started on 2012-04. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01573962?
This trial is sponsored by Astute Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia